<DOC>
	<DOCNO>NCT03088956</DOCNO>
	<brief_summary>The objective study ; ( 1 ) estimate change disease -related cognitive decline 1 year battery cognitive test administer participant early-stage symptomatic Behavioral Variant Frontotemporal Dementia ( bvFTD ) phenotypic variant ; ( 2 ) identify cognitive test brief battery cognitive test sensitive detect bvFTD progression ; ( 3 ) determine optimal schedule administration cognitive test detect bvFTD progression ; ( 4 ) evaluate relationship cognitive test measure behavior , function , caregiver 's burden , quality life ( QOL ) ; ( 5 ) obtain blood sample genetic exploratory biomarkers correlation .</brief_summary>
	<brief_title>Cognitive Change Behavioral Variant Frontotemporal Dementia ( FTD )</brief_title>
	<detailed_description />
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Frontotemporal Dementia</mesh_term>
	<mesh_term>Aphasia , Primary Progressive</mesh_term>
	<mesh_term>Pick Disease Brain</mesh_term>
	<criteria>Key Inclusion Criteria Participants behavioral variant frontotemporal dementia ( bvFTD ) : Must speak understand oral write English . Must probable bvFTD . Must global Clinical Dementia Rating ( CDR ) score 0.51 Mini Mental State Examination ( MMSE ) score â‰¥20 reflect early stage disease . Must 1 informant/caregiver , Investigator 's judgment , frequent sufficient contact participant able provide accurate information participant 's behavior well cognitive functional ability . Must ambulatory able walk assistance institutionalize . Key Inclusion Criteria Healthy Participants : Must speak understand oral write English . Must good general health determine Investigator . Key Exclusion Criteria Participants bvFTD : Concomitant motor neuron disease limb bulbar weakness , opinion Investigator , may affect performance course study . Participants bvFTD motor neuron disease otherwise allow participate . Known presence structural brain lesion could reasonably explain symptom . Diagnosis Alzheimer 's disease and/or know presence Alzheimer 's disease cause mutation PSEN1 , PSEN2 APP ; neuropathological evidence Alzheimer 's disease cause syndrome . History acute chronic neurological psychiatric condition unrelated may confound diagnosis bvFTD , opinion Investigator , may affect cognition , behavior , ability complete study . History severe alcohol substance abuse . History disorder could confound diagnosis bvFTD . Use allow chronic medication dose stable least 4 week prior Screening . Current use psychoactive medication interfere accurate assessment cognition ( assessed Investigator ) Key Exclusion Criteria Healthy Participants : History alcohol substance abuse . Current use psychoactive medication interfere accurate assessment cognition ( assessed Investigator ) . NOTE : Other protocol define Inclusion/Exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>FTD , longitudinal , caregiver , cognitive assessment</keyword>
</DOC>